Abstract
Aim. To assess the correlation of fibrosis biomarkers with parameters of diastolic function (DF) in assessing global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) and preserved left ventricular ejection fraction (EF).Material and methods. We examined 50 patients (100%) with primary STEMI and preserved LVEF at the end of hospitalization. On the 1st day of MI, standard diagnostic investigations were carried out. On the 12th day, the serum concentration of procollagen type I carboxy-terminal propeptide (PICP), N-terminal propeptide of procollagen type III (PIIINP), and galectin-3 was determined, as well as echocardiography was performed to assess left ventricular DF. After 1 year, all participants underwent reassessment of PICP, PIIINP, and galectin-3 serum levels. Echocardiography was also performed with an assessment of DF and LV global longitudinal strain.Results. According to speckle-tracking echocardiography, LV global longitudinal strain was visualized in 30 patients (60%), who were included in the final analysis. In the rest of the patients (40%), the limitations did not allow the technique to be performed. During the hospitalization, signs of diastolic dysfunction (DD) were detected in 5 (16,6%) patients; after 1 year, their number increased by 7 (23,3%). During the 1-year follow-up, the total number of patients with echocardiographic signs of DD was 20 (67%). At the same time, global strain parameters indicated the presence of DD in 23 (77%) patients. However, comparison of the incidence of DD according to echocardiography and using the speckle-tracking technology did not show significant differences (p=0,283). Throughout the entire follow-up period, the concentration of the studied fibrosis markers significantly exceeded the control group values. We recorded associations of global strain parameters with biochemical markers of fibrosis and LV DF indicators.Conclusion. Fibrosis biomarkers (PICP, PIIINP, galectin-3), assessed in the subacute period of MI in patients with preserved EF, correlated with indicators of global myocardial strain, which indicates the potential value of their determination for predicting and detecting DD in the postinfarction period.
Highlights
We examined 50 patients (100%) with primary segment elevation myocardial infarction (STEMI) and preserved LVEF at the end of hospitalization
According tо speckle-tracking echocardiography, LV global longi tudinal strain was visualized in 30 patients (60%), who were included in the final analysis
Материал и методы Обследованы 50 пациентов (100%) с первичным инфарктом миокарда с подъемом сегмента ST (ИМпST) и сохраненной фракцией выброса (ФВ) левого желудочка (ЛЖ) на момент завершения госпитального этапа лечения
Summary
Сокращения: ИМ — инфаркт миокарда, ИМпST — инфаркт миокарда с подъемом сегмента ST, КШ — коронарное шунтирование, ЛЖ — левого желудочка, ОСН — острая сердечная недостаточность, ПИКС — постинфарктный кардио склероз, ФВ — фракция выброса, ЧКВ — чрескожное коронарное вмешательство. Цель: оценить корреляции биохимических МФ (PICP, PIIINP, галектина-3) с параметрами ДФ при оценке глобальной продольной деформации миокарда методом Speckle-tracking у пациентов с перенесенным ИМ с подъемом сегмента ST (ИМпST) и сохраненной фракцией выброса (ФВ) ЛЖ. Заболевания пациентам определена концентрация PICP, PIIINP, галектина-3 в сыворотке венозной крови и проведена эхокардиография (ЭхоКГ) с целью оценки ДФ ЛЖ. Через 1 год всем участникам исследования повторно определена концентрация PICP, PIIINP, галектина-3 в сыворотке венозной крови, проведена ЭхоКГ с оценкой ДФ и глобальной продольной деформации ЛЖ. Определение концентрации PICP, PIIINP, галектина-3 в сыворотке венозной крови проводилось методом иммуноферментного анализа (лабораторные наборы BCM Diagnostics (США)). Для оценки глобальной деформации (ГД) ЛЖ в продольном направлении (Global Longitudinal Strain — GLSLV) использовалась технология “след пятна” (Speckle Tracking Imaging — 2D Strain) и оп-
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
